Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

Показать другие версии (1)

OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...

Полное описание

Библиографические подробности
Главные авторы:	Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A
Формат:	Journal article
Язык:	English
Опубликовано:	2015

Схожие документы

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
по: Balendra, R, и др.
Опубликовано: (2015)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
по: Jones, A, и др.
Опубликовано: (2014)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
по: Balendra, R, и др.
Опубликовано: (2014)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
по: Jones, A, и др.
Опубликовано: (2013)

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
по: Balendra, R, и др.
Опубликовано: (2013)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2002)

A proposed staging system for amyotrophic lateral sclerosis.
по: Roche, J, и др.
Опубликовано: (2012)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2007)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
по: Al-Chalabi, A, и др.
Опубликовано: (2003)

Biomarkers in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2009)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
по: Rutter-Locher, Z, и др.
Опубликовано: (2016)

Amyotrophic lateral sclerosis
по: Leigh P Nigel, и др.
Опубликовано: (2009-02-01)

Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
по: Xueping Chen, и др.
Опубликовано: (2018-06-01)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
по: Turner, M, и др.
Опубликовано: (2020)

Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: Observational study
по: Garcia-Gancedo, L, и др.
Опубликовано: (2019)

Evolution of white matter damage in amyotrophic lateral sclerosis
по: Gabel, M, и др.
Опубликовано: (2020)

Amyotrophic lateral sclerosis and cerebellum
по: Renata Kabiljo, и др.
Опубликовано: (2022-07-01)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
по: Turner, M, и др.
Опубликовано: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
по: Turner, M, и др.
Опубликовано: (2012)

Quantifying disease progression in amyotrophic lateral sclerosis.
по: Simon, N, и др.
Опубликовано: (2014)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
по: Corcia P, и др.
Опубликовано: (2012-08-01)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
по: Johnston, C, и др.
Опубликовано: (2006)

Clinical Controversies in Amyotrophic Lateral Sclerosis
по: Ruaridh Cameron Smail,, и др.
Опубликовано: (2020-07-01)

Clinical psychology and amyotrophic lateral sclerosis
по: Francesco Pagnini, и др.
Опубликовано: (2010-07-01)

Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study
по: Garcia-Gancedo, Luis, и др.
Опубликовано: (2019-12-01)

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis
по: Henderson, R, и др.
Опубликовано: (2018)

Evolution of white matter damage in amyotrophic lateral sclerosis
по: Matt C. Gabel, и др.
Опубликовано: (2020-05-01)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
по: Abrahams, S, и др.
Опубликовано: (1997)

Amyotrophic lateral sclerosis.
по: Kiernan, M, и др.
Опубликовано: (2011)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
по: Scott, K, и др.
Опубликовано: (2009)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
по: Yildiz, O, и др.
Опубликовано: (2025)

The reunification of amyotrophic lateral sclerosis
по: Turner, M
Опубликовано: (2018)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2011)

Neuroimaging in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2012)

The sex ratio in amyotrophic lateral sclerosis: A population based study.
по: Manjaly, Z, и др.
Опубликовано: (2010)

Clinical neurorestorative progress in amyotrophic lateral sclerosis
по: Chen L, и др.
Опубликовано: (2015-08-01)

Progress in clinical diagnosis of amyotrophic lateral sclerosis
по: Qiong YANG, и др.
Опубликовано: (2012-06-01)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
по: Kelly, M, и др.
Опубликовано: (2020)

Amyotrophic lateral sclerosis: Clinical heterogeneity and approaches to classification
по: I. S. Bakulin, и др.
Опубликовано: (2017-11-01)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
по: Fang, F, и др.
Опубликовано: (2013)